Improving healthcare for all

Medexprim a winner at the 2021 Healthcare & Pharmaceutical Awards

In late 2021, the firm in Toulouse scooped two awards: one for its software suite that uses routine care data for therapeutic research purposes, and one for its export development strategy.

26 Jan 2022

Established in 2015, Medexprim specializes in extracting real-world data for clinical research: routine care data from a network of thirty hospitals in Europe. “We aggregate clinical data documenting the progression of the disease. We analyze images in detail to predict whether the treatment will progress positively or negatively,” explains Romain Cazavan, CEO of Medexprim

Medexprim has developed a software suite that can tap into all sources of medical data (clinical, biological [genomic], pharmacological, and imaging data). These data are aggregated in a dedicated and secure clinical research setting, as per the GDPR. Once curated, they are anonymized and forwarded to specialists for analysis. “This is what we call a data lake,” continues Romain Cazavan. “Our job is to ensure its purity and quality. We proceed disease by disease so that the data are relevant and accurate.”

This approach is used in both academic projects and projects sponsored by industry, mainly pharmaceutical firms. 

Medexprim’s approach is disruptive because we compile the four key data types (clinical, biological, pharmacological, and imaging) in one place, with the same standard of quality and a significant number of patients, so that they can be interpreted. It’s unique,” says Romain Cazavan, CEO of Medexprim.

This innovation was named “Best Real-World Hospital Data Management Platform (Europe)” at the Healthcare & Pharmaceutical Awards in December 2021. 

Medexprim has always operated on an international scale. The MedTech firm believes it is vital that university hospitals in Europe all speak the same language. Sharing information across Europe would enable the extension of databases to include several thousand patients, all afflicted by the same disease. The aim is also to reconcile the requirements of hospitals for their own research with those of the pharmaceutical industry. 
This strategy earned Medexprim the Jury’s Favorite prize at the 19th edition of the Trophées de l’International du Numérique, which took place at Business France’s Rencontres Internationales de la French Tech (international French Tech conference) on November 17, 2021.

What are you looking for?